CLNN: Rega marang bathi kanthi panyesuaian wutah Clene Nanomedicine
Clene Inc. aims for the global implementation of nanotherapy to combat multiple sclerosis and ALS. The company's innovative drugs accelerate neuronal energy metabolism, creating a unique method of brain protection. Drug synthesis is carried out in sterile facilities in perfect technical condition. The P/E growth potential metric on GURU.Markets reflects the valuation dynamics, where the value is held at 0.00.
Rincian analitis perusahaan Clene Inc. (CLNN)
- rega saiki lan proyeksi nilai saham:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi Clene Inc.|CLNN - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal clene.com|CLNN - Utang perusahaan|Rasio utang marang nilai buku Clene Nanomedicine|CLNN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Clene|Koefisien jangkoan perantara clene.com
- indikator pendapatan resik lan kelipatan nilai:
CLNN - Bathi resik|Bathi mangsa ngarep Clene Inc.|CLNN - Rasio rega marang bathi|Rega marang bathi mangsa ngarep clene.com|CLNN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Clene Nanomedicine|CLNN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Clene|CLNN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan clene.com|CLNN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Clene Inc.
Analisis fundamental perusahaan:Clene Inc (CLNN)
Clene Inc. specializes in creating innovative nanocatalysts, leveraging a stable staff of highly qualified physicists and chemists. Analyzing the upward trend of the P/E growth ratio allows for an assessment of the effectiveness of this scientific foundation. This metric compares the current earnings multiple with the growth rate, identifying discrepancies in market value relative to development speed. A value below one signals that the asset is undervalued. Fundamental analysis of this ratio enables the determination of the fair share price for the biotech company.
Perusahaan pesaing
Rasio rega marang bathi tumrap wutah BIIB (Biogen Inc)|Pangali PEG NBIX (Neurocrine Biosciences Inc)|Regencell Corp (RGC) - Rega marang bathi kanthi panyesuaian wutah|AXSM - Rasio rega marang bathi tumrap wutah|ACAD (acadia-pharm.com) - Rasio P/E diaturake wutah|XENE: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Viking Therapeutics Inc (VKTX)|Pangali rega marang bathi tumrap wutah SUPN|CPRX: Koefisien bali modal nimbang wutah|Pangali PEG DNLI|Kapitalisasi marang bathi resik kanthi nimbang wutah harmonybiosciences.com|Rasio rega marang bathi tumrap wutah Biohaven BHVN|AMLX: Rasio P/E diaturake wutah|Trevi Pharma - Pangali PEG|Praxis Corp (PRAX) - Pangali rega marang bathi tumrap wutah|AVXL (Anavex Life Sciences) - Pangali rega marang bathi tumrap wutah|CBLL - Kapitalisasi marang bathi resik kanthi nimbang wutah|PRTA (Prothena Corporation plc) - Pangali PEG|Pangali rega marang bathi tumrap wutah Alector Therapeutics (ALEC)|Rasio rega marang bathi tumrap wutah Annexon Inc. (ANNX)|Rasio rega marang bathi tumrap wutah OMER (omeros.com)|Rasio rega marang bathi tumrap wutah Neurogene Inc. NGNE|ACIU: Rasio P/E diaturake wutah|VYGR - Rasio rega marang bathi tumrap wutah|NMRA (Neumora) - Rasio P/E diaturake wutah|Scilex Holding Co. (SCLX) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah TVGN|ACOG (Alpha Cognition Inc) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah cogrx.com CGTX|Pangali rega marang bathi tumrap wutah IKT (Inhibikase Therapeutics, Inc.)|Pangali PEG Cassava Sciences Inc (SAVA)|Rasio rega marang bathi tumrap wutah Assertio ASRT|Koefisien bali modal nimbang wutah COYA|VTGN - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Ovid Therapeutics Inc.|ABOS: Pangali PEG|Pangali rega marang bathi tumrap wutah CervoMed, Inc.|Rasio rega marang bathi tumrap wutah Alterity Therapeutics Ltd.|Rasio rega marang bathi tumrap wutah PEPG|Pangali PEG JUNS|RLMD - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Annovis Bio ANVS|GRCE: Rasio P/E diaturake wutah|Firefly Neuroscience Inc - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Klotho Neurosciences Inc|NRSN (neurosense-tx.com) - Pangali rega marang bathi tumrap wutah|revivapharma.com - Koefisien bali modal nimbang wutah|MTVA (MetaVia Inc.) - Pangali PEG|NeurAxis Inc. (NRXS) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Helius Medical (HSDT)|passagebio.com - Rasio P/E diaturake wutah|Pangali PEG NEUP (Neuphoria Therapeutics)|NERV - Pangali rega marang bathi tumrap wutah|ATHA: Pangali rega marang bathi tumrap wutah|Kapitalisasi marang bathi resik kanthi nimbang wutah Addex Therapeutics Ltd. ADXN|ALZN: Pangali PEG|Pangali rega marang bathi tumrap wutah Cyclerion Therapeutics, Inc.|Rasio rega marang bathi tumrap wutah Protagenic Therapeutics Inc.|Rasio rega marang bathi tumrap wutah KTTA|Rasio rega marang bathi tumrap wutah Cortigent, Inc. (CRGT)|Avenue Therapeutics Inc. - Rasio P/E diaturake wutah|Rasio rega marang bathi tumrap wutah Brainstorm Cell Therapeutics, Inc. BCLI|CARA: Rasio P/E diaturake wutah|CHRO - Rasio rega marang bathi tumrap wutah|ELYM (Eliem Therapeutics) - Rasio P/E diaturake wutah|ITCI: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Longboard Pharmaceuticals Inc (LBPH)|Pangali rega marang bathi tumrap wutah MRNS|Pangali PEG NKGen Biotech Corp|Rasio rega marang bathi tumrap wutah NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Synaptogenix SNPX|Trevena Inc. (TRVN) - Rega marang bathi kanthi panyesuaian wutah|Vigil Neuro - Pangali PEG|Anew Medical Inc. (WENA) - Pangali rega marang bathi tumrap wutah|Cerevel Therapeutics (CERE) - Rasio rega marang bathi tumrap wutah
